We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
-3.77%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$117B
AUM Growth
-$71.4B
(-38%)
Cap. Flow
-$63.6B
Cap. Flow
% of AUM
-54.42%
Top 10 Holdings %
Top 10 Hldgs %
19.61%
Holding
4,580
New
101
Increased
1,974
Reduced
1,229
Closed
1,024
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$190M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$160M |
| 3 |
Microsoft
MSFT
|
+$150M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$136M |
| 5 |
Bank of America
BAC
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$306M |
| 2 |
Linde
LIN
|
+$290M |
| 3 |
Principal Financial Group
PFG
|
+$279M |
| 4 |
Evergy
EVRG
|
+$277M |
| 5 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.91% |
| 2 | Healthcare | 15.27% |
| 3 | Financials | 13.61% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Industrials | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRUE
3076
DELISTED
TrueCar
TRUE
| $305K | ﹤0.01% |
77,342
-2,283
| -3% | -$8.07K |
|
|
MRSN
3077
DELISTED
Mersana Therapeutics
MRSN
| $304K | ﹤0.01% |
3,038
+369
| +14% | +$43.1K |
|
3078
BioXcel Therapeutics
BTAI
$27.8M
| $303K | ﹤0.01% |
906
+58
| +7% | +$16.8K |
|
3079
Cheniere Energy
CQP
$31.3B
| $303K | ﹤0.01% |
5,372
-1,247
| -19% | -$61.9K |
|
3080
N-able
NABL
$940M
| $303K | ﹤0.01% |
33,365
+1,891
| +6% | +$19.9K |
|
3081
Willdan Group
WLDN
$1.3B
| $303K | ﹤0.01% |
9,901
+446
| +5% | +$13.9K |
|
3082
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $302K | ﹤0.01% |
10,493
+419
| +4% | +$11.3K |
|
3083
GrowGeneration
GRWG
$90.7M
| $302K | ﹤0.01% |
32,870
+2,308
| +8% | +$20.8K |
|
3084
Ocular Therapeutix
OCUL
$2.02B
| $302K | ﹤0.01% |
61,043
+15,841
| +35% | +$87.8K |
|
|
HYZN
3085
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $302K | ﹤0.01% |
946
+65
| +7% | +$18K |
|
3086
Angi Inc
ANGI
$196M
| $301K | ﹤0.01% |
5,304
-3,284
| -38% | -$239K |
|
3087
Axogen
AXGN
$2.5B
| $301K | ﹤0.01% |
37,890
+2,152
| +6% | +$18.6K |
|
|
CLVS
3088
DELISTED
Clovis Oncology, Inc.
CLVS
| $301K | ﹤0.01% |
148,714
+21,673
| +17% | +$42.6K |
|
|
OGI
3089
Organigram Holdings
OGI
$139M
| $300K | ﹤0.01% |
45,146
+3,238
| +8% | +$20K |
|
|
AMK
3090
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $300K | ﹤0.01% |
13,503
-356
| -3% | -$8.4K |
|
3091
Funko
FNKO
$328M
| $298K | ﹤0.01% |
17,311
+5,643
| +48% | +$98.6K |
|
3092
Vertex
VERX
$1.94B
| $298K | ﹤0.01% |
19,430
+2,037
| +12% | +$28.5K |
|
|
ME
3093
DELISTED
23andMe Holding Co
ME
| $296K | ﹤0.01% |
3,875
+2,089
| +117% | +$191K |
|
|
AEVA
3094
Aeva Technologies
AEVA
$1.82B
| $295K | ﹤0.01% |
13,677
-428
| -3% | -$10.5K |
|
|
LL
3095
DELISTED
LL Flooring Holdings, Inc.
LL
| $295K | ﹤0.01% |
21,073
-522
| -2% | -$7.97K |
|
3096
Comtech Telecommunications
CMTL
$51.8M
| $294K | ﹤0.01% |
18,784
-425
| -2% | -$8.36K |
|
3097
New Fortress Energy
NFE
$101M
| $291K | ﹤0.01% |
+6,831
| New | +$184K |
|
3098
Novartis
NVS
$297B
| $291K | ﹤0.01% |
3,314
-2,647
| -44% | -$229K |
|
3099
ProShares Pet Care ETF
PAWZ
$33.6M
| $291K | ﹤0.01% |
+4,374
| New | +$293K |
|
3100
Universal Insurance Holdings
UVE
$1.23B
| $290K | ﹤0.01% |
21,485
-458
| -2% | -$6.87K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2022 Portfolio in Review
As of Q1 2022, Credit Suisse held 4,580 positions worth $117B, down 38% from $188B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Credit Suisse withdrew a net $63.6B in Q1 2022, closing 1,024 positions and reducing 1,229 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $240M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in AgileThought Inc worth $43.7M.
- Credit Suisse's largest Q1 2022 buy was AgileThought Inc: 9,605,775 shares worth $43.7M.
- Credit Suisse added most to S&P Global in Q1 2022, an estimated $190M increase.
- Credit Suisse's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $306M.
- Credit Suisse fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $240M.
- Credit Suisse's ten largest holdings make up 20% of its $117B portfolio in Q1 2022.
- Credit Suisse opened 101 new positions and closed 1,024 in Q1 2022.
- Credit Suisse's portfolio value fell 38% quarter-over-quarter to $117B.
Based on Credit Suisse's 13F filing for Q1 2022, filed 16 May 2022.